- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CDX-301
Total 6121 results
-
Dr. Anupam SehgalTaysha Gene Therapies, Inc.; GlycoNetActive, not recruitingInfantile GM2 Gangliosidosis (Disorder)Canada
-
Innovo Therapeutics, Inc.Completed
-
Invenux, LLCState University of New York - Downstate Medical CenterActive, not recruitingSickle Cell Disease | Sickle-Beta Zero ThalassemiaUnited States
-
Ossium Health, Inc.Withdrawn
-
Pipeline Therapeutics, Inc.Completed
-
SignalChem Lifesciences CorporationSyneos HealthCompletedFood-drug InteractionCanada
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Abeona Therapeutics, IncTerminatedMucopolysaccharidosis III-BUnited States, Germany, France
-
Suzhou Connect Biopharmaceuticals, Ltd.Completed
-
Lumen Bioscience, Inc.CompletedC. Diff. InfectionsAustralia
-
Forte Biosciences, Inc.Terminated
-
PfizerCompletedReduction in Hypertrophic Skin ScarringUnited States
-
Protagonist Therapeutics, Inc.CompletedChronic Anemia | β-thalassemia | Ineffective ErythropoiesisUnited States, Malaysia, Turkey, Thailand, United Kingdom, Italy, Lebanon, Tunisia, Greece
-
Stargazer Pharmaceuticals, Inc.Completed
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
AL-S PharmaUnknownAmyotrophic Lateral SclerosisCanada
-
Otonomy, Inc.Completed
-
United BioSource, LLCAveXis, Inc.Approved for marketing
-
ADC Therapeutics S.A.TerminatedAdvanced Solid TumorsUnited States
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
FibroGenTerminatedFocal Segmental GlomerulosclerosisUnited States
-
Curis, Inc.Terminated
-
Minerva NeurosciencesCompletedHealthy SubjectsIreland
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Sarcoma Alliance for Research through CollaborationThreshold PharmaceuticalsNo longer availableSoft Tissue Sarcoma
-
Eleven BiotherapeuticsWithdrawn
-
Threshold PharmaceuticalsUnknown
-
Dolorgiet GmbH & Co. KGd.s.h. statistical services GmbH; CenTrial GmbHCompletedActinic Keratosis Olsen Grade I/IIGermany
-
HealthpointCompleted
-
Cerenis Therapeutics, SACompleted
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
Akros Pharma Inc.Completed
-
NorgineCompletedPostoperative IleusUnited Kingdom
-
M.D. Anderson Cancer CenterAlaunos TherapeuticsCompleted
-
Threshold PharmaceuticalsCompletedHypoxia | TumorsUnited States
-
C.B. Fleet Company, Inc.CompletedBowel Cleansing Prior to ColonoscopyUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedColorectal Neoplasms | Rectal Neoplasms | Colonic Neoplasms
-
Danube Pharmaceuticals, Inc.CompletedOcular Hypertension | Glaucoma | Elevated IOPUnited Kingdom
-
FibroGenCompletedDiabetes MellitusUnited States
-
Celgene CorporationTerminatedMyeloid LeukemiaUnited States
-
Bioray LaboratoriesXiangya Hospital of Central South University; First Affiliated Hospital of... and other collaboratorsEnrolling by invitation
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedUlcerative ColitisUnited States
-
Dynavax Technologies CorporationMerck Sharp & Dohme LLCTerminatedMetastatic Melanoma | Head Neck CancerUnited States, Germany, New Zealand, Australia
-
M.D. Anderson Cancer CenterBrainlab AGNot yet recruitingSpinal Cord | Metastatic Epidural | Spine StereotacticUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Ying WangRecruiting
-
University of NebraskaRecruiting
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)CompletedHIV PreventionUnited States